Case report: Fluctuating tumor markers in a boy with gonadotropin-releasing hormone-independent precocious puberty induced by a pineal germ cell tumor.
anastrozole
aromatase inhibitors
bicalutamide
chorionic gonadotropin
germ cell and embryonal neoplasms
pineal cyst
precocious puberty
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
05
2022
accepted:
04
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
10
9
2022
Statut:
epublish
Résumé
GnRH-independent precocious puberty (GIPP) can be the presenting clinical picture experienced by patients with secreting germ cell tumor (GCT). Indeed, as luteinizing hormone (LH) and human chorionic gonadotropin (hCG) share identical α-subunits and similar β-subunits, an increased secretion of β-hCG may result in a precocious activation of Leydig cells. Though the co-occurrence of raised β-hCG levels and signs of precocious virilization usually prompts a complete oncological work-up, the diagnostic and therapeutic management of GCT-induced GIPP may be challenging. We report the case of a 6.2 year-old boy presenting with clinical and biochemical findings consistent with GIPP (discrepancy between overt virilization and pre-pubertal testicular volume, suppressed gonadotropins and remarkably raised testosterone). Brain imaging detected a bilobed cyst of the pineal gland, while serum and cerebrospinal baseline assessment initially ruled out raised alpha-fetoprotein or β-hCG levels. Nevertheless, a strict biochemical follow-up highlighted a fluctuant trend of tumor markers, with a more aggressive behavior and recurrent erections occurring as a result of unpredictable phases of raised testosterone and serum/cerebrospinal β-hCG, followed by sudden spontaneous decrease. Accordingly, a secreting pineal GCT was suspected. Given the fluctuating trend of tumor markers, surgery was initially kept on hold and a combined treatment with bicalutamide (androgen receptor blocker) and anastrozole (aromatase inhibitor) was undertaken in order to prevent the patient from experiencing further virilization and excessive bone age maturation. Subsequently, a progression in the size of the pineal tumor prompted surgical resection and a diagnosis of secreting GCT was histologically confirmed. Accordingly, the patient was started on adjuvant chemo- and radiotherapy. Antineoplastic treatment was followed by persistent and remarkable decrease of tumor markers and by a complete pubertal arrest. We reported the challenging diagnosis of a secreting pineal GCT in a patient with GIPP and a fluctuating trend of tumor markers, testosterone levels and associated clinical signs, hence prompting the indication for a systematic assessment and a strict monitoring whenever a patient with GnRH-independent precocious puberty shows clinical or radiological markers potentially consistent with a GCT.
Identifiants
pubmed: 36081625
doi: 10.3389/fped.2022.940656
pmc: PMC9445167
doi:
Types de publication
Case Reports
Langues
eng
Pagination
940656Informations de copyright
Copyright © 2022 Cattoni and Albanese.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Clin Res Pediatr Endocrinol. 2020 Aug 06;13(2):239-244
pubmed: 32757547
Eur J Cancer. 1998 Jan;34(1):104-10
pubmed: 9624246
Neurology. 2007 May 15;68(20):1668-73
pubmed: 17502547
Eur J Immunol. 2017 Jul;47(7):1232-1242
pubmed: 28555838
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):803-8
pubmed: 15936563
Pediatrics. 2010 Sep;126(3):e728-33
pubmed: 20713483
Pediatr Hematol Oncol. 2001 Jan-Feb;18(1):11-26
pubmed: 11205836
Neuroradiology. 2017 Dec;59(12):1265-1273
pubmed: 28942520
J Pediatr Endocrinol Metab. 2010 Oct;23(10):999-1009
pubmed: 21158211
AJNR Am J Neuroradiol. 2013 Oct;34(10):2021-5
pubmed: 23811972
Neuro Oncol. 2008 Apr;10(2):121-30
pubmed: 18287340
Pediatr Radiol. 2013 Dec;43(12):1577-83
pubmed: 23852563
Indian Pediatr. 2010 Feb;47(2):193-4
pubmed: 20228436
Eur J Pediatr. 2021 Oct;180(10):3073-3087
pubmed: 33745030
J Pediatr. 2013 Nov;163(5):1448-53
pubmed: 23896184
Lancet Oncol. 2017 Jun;18(6):719-731
pubmed: 28410997
J Neurosurg Pediatr. 2016 Nov;18(5):573-577
pubmed: 27391806
J Pediatr Endocrinol Metab. 2019 Apr 24;32(4):403-407
pubmed: 30849047
Neuro Endocrinol Lett. 2004 Jun;25(3):173-5
pubmed: 15349080
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931